Intellia Therapeutics (NTLA) EPS (Basic) (2015 - 2026)
Intellia Therapeutics (NTLA) posted quarterly EPS (Basic) of -$1.62 for Q1 2026, up 34.16% year-over-year from -$1.21 in Q1 2025, and down 90.46% quarter-over-quarter from -$0.85 in Q4 2025.
Powered by 
Analysis
Intellia Therapeutics (NTLA) EPS (Basic) (2015 - 2026) Analysis & Trends
Intellia Therapeutics (NTLA) has reported EPS (Basic) for 12 consecutive years, with -$1.62 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 34.16% year-over-year to -$1.62; the TTM figure through Mar 2026 stood at -$5.28 (up 18.19% YoY), while the FY2025 annual figure was -$12.24, up 4.71% from the prior year.
- EPS (Basic) declined to -$1.62 in Q1 2026 per NTLA's latest filing, from -$0.85 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.85 in Q4 2025 and bottomed at -$7.27 in Q4 2022.
- Historically, EPS (Basic) has averaged -$2.28 across 5 years, with a median of -$1.82 in 2023.
- Annual changes were most pronounced in 2022 — EPS (Basic) jumped 99.87% — and 2025, when it tumbled 82.36%.
- Intellia Therapeutics' EPS (Basic) stood at -$7.27 in 2022, then surged by 74.68% to -$1.84 in 2023, then soared by 30.64% to -$1.28 in 2024, then surged by 33.29% to -$0.85 in 2025, then plunged by 90.46% to -$1.62 in 2026.
- Business Quant data shows NTLA's EPS (Basic) at -$1.62 in Q1 2026, -$0.85 in Q4 2025, and -$2.02 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Intellia Therapeutics | 1.70 Bn | 1.70 Bn | - | -0.80 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.80 |
| Mar 31, 2026 | -0.80 |
| Dec 31, 2025 | -0.85 |
| Sep 30, 2025 | -0.95 |
| Jun 30, 2025 | -0.99 |
| Mar 31, 2025 | -1.08 |
| Dec 31, 2024 | -1.27 |
| Sep 30, 2024 | -1.31 |
| Jun 30, 2024 | -1.31 |
| Mar 31, 2024 | -1.06 |
| Dec 31, 2023 | -1.44 |
| Sep 30, 2023 | -1.34 |
| Jun 30, 2023 | -1.36 |
| Mar 31, 2023 | -1.14 |
| Dec 31, 2022 | -1.36 |
| Sep 30, 2022 | -1.36 |
| Jun 30, 2022 | -1.29 |
| Mar 31, 2022 | -1.92 |
| Dec 31, 2021 | -1.13 |
| Sep 30, 2021 | -0.97 |